Exane Derivatives Nu Skin Enterprises, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Nu Skin Enterprises, Inc. stock. As of the latest transaction made, Exane Derivatives holds 5 shares of NUS stock, worth $31. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$31
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NUS
# of Institutions
199Shares Held
40.8MCall Options Held
31.7KPut Options Held
243K-
Black Rock Inc. New York, NY8.12MShares$51.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.55MShares$41.5 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.39MShares$15.2 Million0.06% of portfolio
-
State Street Corp Boston, MA1.98MShares$12.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.76MShares$11.1 Million0.03% of portfolio
About NU SKIN ENTERPRISES, INC.
- Ticker NUS
- Exchange NYSE
- Sector Consumer Defensive
- Industry Household & Personal Products
- Shares Outstandng 50,380,600
- Market Cap $319M
- Description
- Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The...